ISSN: 1064-1297
Journal Home
Journal Guideline
Experimental and Clinical Psychopharmacology Q2 Unclaimed
Experimental and Clinical Psychopharmacology is a journal indexed in SJR in Pharmacology and Psychiatry and Mental Health with an H index of 101. It has an SJR impact factor of 0,827 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,827.
Experimental and Clinical Psychopharmacology focuses its scope in these topics and keywords: stimuli, performanceinteractive, neurodegeneration, motivational, modeleffects, locomotor, immunological, genotype, gender, potentiation, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy:
Type of publications:
Publication frecuency: -
- €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0,827
SJR Impact factor101
H Index63
Total Docs (Last Year)309
Total Docs (3 years)3335
Total Refs740
Total Cites (3 years)308
Citable Docs (3 years)2.43
Cites/Doc (2 years)52.94
Ref/DocOther journals with similar parameters
Drug Safety - Case Reports Q2
Cancer Biology and Therapy Q2
Journal of Pharmacological Sciences Q2
AIDS Research and Therapy Q2
Pharmacological Reports Q2
Compare this journals
Aims and Scope
Best articles by citations
The impact of imagining personalized versus standardized urge scenarios on cigarette craving and autonomic reactivity.
View moreMeasuring Adolescent Drug Abuse and Psychosocial Factors in Four Ethnic Groups of Drug-Abusing Boys.
View moreNew Editor Appointed for Journal of Occupational Health Psychology.
View moreNeurocognitive impairment associated with alcohol use disorders: Implications for treatment.
View moreSilver acetate interactions with nicotine and non-nicotine smoke components.
View moreThe Effect of Tobacco Abstinence on Recognition Memory, Digit Span Recall, and Attentional Vigilance.
View moreContraints on information processing under alcohol in the context of response execution and response suppression.
View moreExamining the addictive-like properties of binge eating using an animal model of sugar dependence.
View moreHow does regulation of drug intake come about? Comment on Lynch and Carroll (2001).
View moreNew Editors Appointed, 2006-2011.
View moreCognitive remediation in the treatment of stimulant abuse disorders: A research agenda.
View moreCigarette abstinence impairs memory and metacognition despite administration of 2 mg nicotine gum.
View moreMeasurement of smoking behavior: Comparison of self-reports, returned cigarette butts, and toxicant levels.
View moreSatiety threshold regulates maintained self-administration: Comment of Lynch and Carroll (2001).
View moreAggressiveness, family history of alcoholism, and the heart rate response to alcohol intoxication.
View moreEffects of triazolam, 8-OH-DPAT, and buspirone on repeated acquisition in squirrel monkeys.
View moreIntra-Administration Associations and Withdrawal Symptoms: Morphine-Elicited Morphine Withdrawal.
View moreEffects of consuming a diet high in fat and/or sugar on the locomotor effects of acute and repeated cocaine in male and female C57BL/6J mice.
View moreThe effects of venlafaxine on the subjective, reinforcing, and cardiovascular effects of cocaine in opioid-dependent and non-opioid-dependent humans.
View moreExpectancy challenge and drinking reduction: Process and structure in the alcohol expectancy network.
View moreA verification of psychostimulant-induced improvement in sustained attention in rats: Effects of d-amphetamine, nicotine, and pemoline.
View moreA behavioral economic analysis of the nonmedical use of prescription drugs among young adults.
View moreGenetic influences on delayed reward discounting: A genome-wide prioritized subset approach.
View moreGenetic predictors of cue- and stress-induced cigarette craving: An exploratory study.
View more
Comments